Predictors of responses to immune checkpoint blockade in advanced melanomaNicolas Jacquelot, Laurence Zitvogel, Benjamin Weide et al.|Nature Communications|2017Cited by 201
Efficacy of Immunotherapy in Patients with Metastatic Mucosal or Uveal MelanomaC. Mignard, P. Joly, Aurélie Deschamps Huvier et al.|Journal of Oncology|2018Cited by 82
Efficacy of immunotherapy in patients with metastatic mucosal or uveal melanomaC. Mignard, P. Joly, A. Deschamps-Huvier et al.|Annals of Oncology|2018Cited by 13
Effectiveness and safety of nivolumab in patients with advanced melanoma: A multicenter, observational studyS. Monestier, Stéphane Dalle, Laurent Mortier et al.|International Journal of Cancer|2021Cited by 9
Management of adjuvant settings for Stage III melanoma patients in France prior to checkpoint inhibitors: epidemiological data from the RIC-Mel databaseStéphane Dalle, Brigitte Dréno, Émilie Varey et al.|European Journal of Dermatology|2020Cited by 3